nodes	percent_of_prediction	percent_of_DWPC	metapath
Tadalafil—Mediastinal disorder—Sorafenib—thyroid cancer	0.00365	0.00365	CcSEcCtD
Tadalafil—Constipation—Vandetanib—thyroid cancer	0.00365	0.00365	CcSEcCtD
Tadalafil—Pain—Vandetanib—thyroid cancer	0.00365	0.00365	CcSEcCtD
Tadalafil—Scotoma—Doxorubicin—thyroid cancer	0.00363	0.00363	CcSEcCtD
Tadalafil—Mental disorder—Sorafenib—thyroid cancer	0.00355	0.00355	CcSEcCtD
Tadalafil—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00349	0.00349	CcSEcCtD
Tadalafil—Cardiovascular disorder—Epirubicin—thyroid cancer	0.00339	0.00339	CcSEcCtD
Tadalafil—Muscle spasms—Sorafenib—thyroid cancer	0.00339	0.00339	CcSEcCtD
Tadalafil—Abdominal pain—Vandetanib—thyroid cancer	0.00337	0.00337	CcSEcCtD
Tadalafil—Rectal haemorrhage—Epirubicin—thyroid cancer	0.0033	0.0033	CcSEcCtD
Tadalafil—Bone disorder—Epirubicin—thyroid cancer	0.0033	0.0033	CcSEcCtD
Tadalafil—Lacrimation increased—Epirubicin—thyroid cancer	0.00323	0.00323	CcSEcCtD
Tadalafil—Angioedema—Sorafenib—thyroid cancer	0.00322	0.00322	CcSEcCtD
Tadalafil—Syncope—Sorafenib—thyroid cancer	0.00316	0.00316	CcSEcCtD
Tadalafil—Cardiovascular disorder—Doxorubicin—thyroid cancer	0.00314	0.00314	CcSEcCtD
Tadalafil—Loss of consciousness—Sorafenib—thyroid cancer	0.0031	0.0031	CcSEcCtD
Tadalafil—Cough—Sorafenib—thyroid cancer	0.00308	0.00308	CcSEcCtD
Tadalafil—Asthenia—Vandetanib—thyroid cancer	0.00306	0.00306	CcSEcCtD
Tadalafil—Rectal haemorrhage—Doxorubicin—thyroid cancer	0.00305	0.00305	CcSEcCtD
Tadalafil—Bone disorder—Doxorubicin—thyroid cancer	0.00305	0.00305	CcSEcCtD
Tadalafil—Hypertension—Sorafenib—thyroid cancer	0.00304	0.00304	CcSEcCtD
Tadalafil—Pruritus—Vandetanib—thyroid cancer	0.00302	0.00302	CcSEcCtD
Tadalafil—Neck pain—Epirubicin—thyroid cancer	0.00302	0.00302	CcSEcCtD
Tadalafil—Arthralgia—Sorafenib—thyroid cancer	0.003	0.003	CcSEcCtD
Tadalafil—Myalgia—Sorafenib—thyroid cancer	0.003	0.003	CcSEcCtD
Tadalafil—Lacrimation increased—Doxorubicin—thyroid cancer	0.00299	0.00299	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00298	0.00298	CcSEcCtD
Tadalafil—Dry mouth—Sorafenib—thyroid cancer	0.00294	0.00294	CcSEcCtD
Tadalafil—Diarrhoea—Vandetanib—thyroid cancer	0.00292	0.00292	CcSEcCtD
Tadalafil—Infection—Sorafenib—thyroid cancer	0.00286	0.00286	CcSEcCtD
Tadalafil—Shock—Sorafenib—thyroid cancer	0.00283	0.00283	CcSEcCtD
Tadalafil—Nervous system disorder—Sorafenib—thyroid cancer	0.00282	0.00282	CcSEcCtD
Tadalafil—Dizziness—Vandetanib—thyroid cancer	0.00282	0.00282	CcSEcCtD
Tadalafil—Skin disorder—Sorafenib—thyroid cancer	0.0028	0.0028	CcSEcCtD
Tadalafil—Neck pain—Doxorubicin—thyroid cancer	0.00279	0.00279	CcSEcCtD
Tadalafil—Oesophagitis—Epirubicin—thyroid cancer	0.00272	0.00272	CcSEcCtD
Tadalafil—Vomiting—Vandetanib—thyroid cancer	0.00271	0.00271	CcSEcCtD
Tadalafil—Rash—Vandetanib—thyroid cancer	0.00269	0.00269	CcSEcCtD
Tadalafil—Dermatitis—Vandetanib—thyroid cancer	0.00269	0.00269	CcSEcCtD
Tadalafil—Headache—Vandetanib—thyroid cancer	0.00267	0.00267	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00262	0.00262	CcSEcCtD
Tadalafil—Dyspnoea—Sorafenib—thyroid cancer	0.00257	0.00257	CcSEcCtD
Tadalafil—Nausea—Vandetanib—thyroid cancer	0.00253	0.00253	CcSEcCtD
Tadalafil—Dyspepsia—Sorafenib—thyroid cancer	0.00253	0.00253	CcSEcCtD
Tadalafil—Oesophagitis—Doxorubicin—thyroid cancer	0.00252	0.00252	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00248	0.00248	CcSEcCtD
Tadalafil—Fatigue—Sorafenib—thyroid cancer	0.00248	0.00248	CcSEcCtD
Tadalafil—Pain—Sorafenib—thyroid cancer	0.00246	0.00246	CcSEcCtD
Tadalafil—Constipation—Sorafenib—thyroid cancer	0.00246	0.00246	CcSEcCtD
Tadalafil—Eye pain—Epirubicin—thyroid cancer	0.0024	0.0024	CcSEcCtD
Tadalafil—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00235	0.00235	CcSEcCtD
Tadalafil—Hot flush—Epirubicin—thyroid cancer	0.00231	0.00231	CcSEcCtD
Tadalafil—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.00229	0.00229	CcSEcCtD
Tadalafil—Menopausal symptoms—Epirubicin—thyroid cancer	0.00229	0.00229	CcSEcCtD
Tadalafil—Urticaria—Sorafenib—thyroid cancer	0.00229	0.00229	CcSEcCtD
Tadalafil—Abdominal pain—Sorafenib—thyroid cancer	0.00227	0.00227	CcSEcCtD
Tadalafil—Renal impairment—Epirubicin—thyroid cancer	0.00227	0.00227	CcSEcCtD
Tadalafil—Eye pain—Doxorubicin—thyroid cancer	0.00222	0.00222	CcSEcCtD
Tadalafil—Cerebrovascular accident—Epirubicin—thyroid cancer	0.00221	0.00221	CcSEcCtD
Tadalafil—Pain in extremity—Epirubicin—thyroid cancer	0.00216	0.00216	CcSEcCtD
Tadalafil—Hot flush—Doxorubicin—thyroid cancer	0.00214	0.00214	CcSEcCtD
Tadalafil—Migraine—Epirubicin—thyroid cancer	0.00213	0.00213	CcSEcCtD
Tadalafil—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.00212	0.00212	CcSEcCtD
Tadalafil—Menopausal symptoms—Doxorubicin—thyroid cancer	0.00212	0.00212	CcSEcCtD
Tadalafil—Hypersensitivity—Sorafenib—thyroid cancer	0.00212	0.00212	CcSEcCtD
Tadalafil—Renal impairment—Doxorubicin—thyroid cancer	0.0021	0.0021	CcSEcCtD
Tadalafil—Face oedema—Epirubicin—thyroid cancer	0.00209	0.00209	CcSEcCtD
Tadalafil—Asthenia—Sorafenib—thyroid cancer	0.00206	0.00206	CcSEcCtD
Tadalafil—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.00204	0.00204	CcSEcCtD
Tadalafil—Pruritus—Sorafenib—thyroid cancer	0.00204	0.00204	CcSEcCtD
Tadalafil—Pain in extremity—Doxorubicin—thyroid cancer	0.002	0.002	CcSEcCtD
Tadalafil—Liver function test abnormal—Epirubicin—thyroid cancer	0.002	0.002	CcSEcCtD
Tadalafil—Orthostatic hypotension—Epirubicin—thyroid cancer	0.00198	0.00198	CcSEcCtD
Tadalafil—Abdominal pain upper—Epirubicin—thyroid cancer	0.00198	0.00198	CcSEcCtD
Tadalafil—Migraine—Doxorubicin—thyroid cancer	0.00197	0.00197	CcSEcCtD
Tadalafil—Diarrhoea—Sorafenib—thyroid cancer	0.00197	0.00197	CcSEcCtD
Tadalafil—Breast disorder—Epirubicin—thyroid cancer	0.00196	0.00196	CcSEcCtD
Tadalafil—Nasopharyngitis—Epirubicin—thyroid cancer	0.00193	0.00193	CcSEcCtD
Tadalafil—Face oedema—Doxorubicin—thyroid cancer	0.00193	0.00193	CcSEcCtD
Tadalafil—Gastritis—Epirubicin—thyroid cancer	0.00191	0.00191	CcSEcCtD
Tadalafil—Dizziness—Sorafenib—thyroid cancer	0.0019	0.0019	CcSEcCtD
Tadalafil—Influenza—Epirubicin—thyroid cancer	0.00187	0.00187	CcSEcCtD
Tadalafil—Dysphagia—Epirubicin—thyroid cancer	0.00187	0.00187	CcSEcCtD
Tadalafil—Liver function test abnormal—Doxorubicin—thyroid cancer	0.00185	0.00185	CcSEcCtD
Tadalafil—Vomiting—Sorafenib—thyroid cancer	0.00183	0.00183	CcSEcCtD
Tadalafil—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.00183	0.00183	CcSEcCtD
Tadalafil—Abdominal pain upper—Doxorubicin—thyroid cancer	0.00183	0.00183	CcSEcCtD
Tadalafil—Angina pectoris—Epirubicin—thyroid cancer	0.00182	0.00182	CcSEcCtD
Tadalafil—Rash—Sorafenib—thyroid cancer	0.00181	0.00181	CcSEcCtD
Tadalafil—Dermatitis—Sorafenib—thyroid cancer	0.00181	0.00181	CcSEcCtD
Tadalafil—Breast disorder—Doxorubicin—thyroid cancer	0.00181	0.00181	CcSEcCtD
Tadalafil—Headache—Sorafenib—thyroid cancer	0.0018	0.0018	CcSEcCtD
Tadalafil—Bronchitis—Epirubicin—thyroid cancer	0.0018	0.0018	CcSEcCtD
Tadalafil—Nasopharyngitis—Doxorubicin—thyroid cancer	0.00179	0.00179	CcSEcCtD
Tadalafil—Gastritis—Doxorubicin—thyroid cancer	0.00177	0.00177	CcSEcCtD
Tadalafil—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.00174	0.00174	CcSEcCtD
Tadalafil—Dysphagia—Doxorubicin—thyroid cancer	0.00173	0.00173	CcSEcCtD
Tadalafil—Influenza—Doxorubicin—thyroid cancer	0.00173	0.00173	CcSEcCtD
Tadalafil—Nausea—Sorafenib—thyroid cancer	0.00171	0.00171	CcSEcCtD
Tadalafil—Angina pectoris—Doxorubicin—thyroid cancer	0.00169	0.00169	CcSEcCtD
Tadalafil—Infestation NOS—Epirubicin—thyroid cancer	0.00167	0.00167	CcSEcCtD
Tadalafil—Infestation—Epirubicin—thyroid cancer	0.00167	0.00167	CcSEcCtD
Tadalafil—Bronchitis—Doxorubicin—thyroid cancer	0.00166	0.00166	CcSEcCtD
Tadalafil—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.00165	0.00165	CcSEcCtD
Tadalafil—Renal failure—Epirubicin—thyroid cancer	0.00164	0.00164	CcSEcCtD
Tadalafil—Urinary tract infection—Epirubicin—thyroid cancer	0.00162	0.00162	CcSEcCtD
Tadalafil—Conjunctivitis—Epirubicin—thyroid cancer	0.00162	0.00162	CcSEcCtD
Tadalafil—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.00161	0.00161	CcSEcCtD
Tadalafil—Sweating—Epirubicin—thyroid cancer	0.0016	0.0016	CcSEcCtD
Tadalafil—Haematuria—Epirubicin—thyroid cancer	0.00159	0.00159	CcSEcCtD
Tadalafil—Epistaxis—Epirubicin—thyroid cancer	0.00157	0.00157	CcSEcCtD
Tadalafil—Infestation NOS—Doxorubicin—thyroid cancer	0.00154	0.00154	CcSEcCtD
Tadalafil—Infestation—Doxorubicin—thyroid cancer	0.00154	0.00154	CcSEcCtD
Tadalafil—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.00153	0.00153	CcSEcCtD
Tadalafil—Renal failure—Doxorubicin—thyroid cancer	0.00152	0.00152	CcSEcCtD
Tadalafil—Haemoglobin—Epirubicin—thyroid cancer	0.0015	0.0015	CcSEcCtD
Tadalafil—Rhinitis—Epirubicin—thyroid cancer	0.0015	0.0015	CcSEcCtD
Tadalafil—Conjunctivitis—Doxorubicin—thyroid cancer	0.0015	0.0015	CcSEcCtD
Tadalafil—Urinary tract infection—Doxorubicin—thyroid cancer	0.0015	0.0015	CcSEcCtD
Tadalafil—Haemorrhage—Epirubicin—thyroid cancer	0.0015	0.0015	CcSEcCtD
Tadalafil—Hypoaesthesia—Epirubicin—thyroid cancer	0.00149	0.00149	CcSEcCtD
Tadalafil—Pharyngitis—Epirubicin—thyroid cancer	0.00149	0.00149	CcSEcCtD
Tadalafil—Sweating—Doxorubicin—thyroid cancer	0.00148	0.00148	CcSEcCtD
Tadalafil—Urinary tract disorder—Epirubicin—thyroid cancer	0.00148	0.00148	CcSEcCtD
Tadalafil—Oedema peripheral—Epirubicin—thyroid cancer	0.00147	0.00147	CcSEcCtD
Tadalafil—Haematuria—Doxorubicin—thyroid cancer	0.00147	0.00147	CcSEcCtD
Tadalafil—Connective tissue disorder—Epirubicin—thyroid cancer	0.00147	0.00147	CcSEcCtD
Tadalafil—Urethral disorder—Epirubicin—thyroid cancer	0.00147	0.00147	CcSEcCtD
Tadalafil—Epistaxis—Doxorubicin—thyroid cancer	0.00146	0.00146	CcSEcCtD
Tadalafil—Erythema multiforme—Epirubicin—thyroid cancer	0.00142	0.00142	CcSEcCtD
Tadalafil—Eye disorder—Epirubicin—thyroid cancer	0.0014	0.0014	CcSEcCtD
Tadalafil—Tinnitus—Epirubicin—thyroid cancer	0.0014	0.0014	CcSEcCtD
Tadalafil—Haemoglobin—Doxorubicin—thyroid cancer	0.00139	0.00139	CcSEcCtD
Tadalafil—Cardiac disorder—Epirubicin—thyroid cancer	0.00139	0.00139	CcSEcCtD
Tadalafil—Flushing—Epirubicin—thyroid cancer	0.00139	0.00139	CcSEcCtD
Tadalafil—Rhinitis—Doxorubicin—thyroid cancer	0.00139	0.00139	CcSEcCtD
Tadalafil—Haemorrhage—Doxorubicin—thyroid cancer	0.00139	0.00139	CcSEcCtD
Tadalafil—Hypoaesthesia—Doxorubicin—thyroid cancer	0.00138	0.00138	CcSEcCtD
Tadalafil—Pharyngitis—Doxorubicin—thyroid cancer	0.00137	0.00137	CcSEcCtD
Tadalafil—Urinary tract disorder—Doxorubicin—thyroid cancer	0.00137	0.00137	CcSEcCtD
Tadalafil—Oedema peripheral—Doxorubicin—thyroid cancer	0.00136	0.00136	CcSEcCtD
Tadalafil—Connective tissue disorder—Doxorubicin—thyroid cancer	0.00136	0.00136	CcSEcCtD
Tadalafil—Angiopathy—Epirubicin—thyroid cancer	0.00136	0.00136	CcSEcCtD
Tadalafil—Urethral disorder—Doxorubicin—thyroid cancer	0.00136	0.00136	CcSEcCtD
Tadalafil—Immune system disorder—Epirubicin—thyroid cancer	0.00135	0.00135	CcSEcCtD
Tadalafil—Mediastinal disorder—Epirubicin—thyroid cancer	0.00135	0.00135	CcSEcCtD
Tadalafil—Mental disorder—Epirubicin—thyroid cancer	0.00131	0.00131	CcSEcCtD
Tadalafil—Erythema multiforme—Doxorubicin—thyroid cancer	0.00131	0.00131	CcSEcCtD
Tadalafil—Eye disorder—Doxorubicin—thyroid cancer	0.00129	0.00129	CcSEcCtD
Tadalafil—Tinnitus—Doxorubicin—thyroid cancer	0.00129	0.00129	CcSEcCtD
Tadalafil—Flushing—Doxorubicin—thyroid cancer	0.00129	0.00129	CcSEcCtD
Tadalafil—Cardiac disorder—Doxorubicin—thyroid cancer	0.00129	0.00129	CcSEcCtD
Tadalafil—Back pain—Epirubicin—thyroid cancer	0.00126	0.00126	CcSEcCtD
Tadalafil—Angiopathy—Doxorubicin—thyroid cancer	0.00126	0.00126	CcSEcCtD
Tadalafil—Muscle spasms—Epirubicin—thyroid cancer	0.00125	0.00125	CcSEcCtD
Tadalafil—Immune system disorder—Doxorubicin—thyroid cancer	0.00125	0.00125	CcSEcCtD
Tadalafil—Mediastinal disorder—Doxorubicin—thyroid cancer	0.00125	0.00125	CcSEcCtD
Tadalafil—Vision blurred—Epirubicin—thyroid cancer	0.00123	0.00123	CcSEcCtD
Tadalafil—Mental disorder—Doxorubicin—thyroid cancer	0.00121	0.00121	CcSEcCtD
Tadalafil—Vertigo—Epirubicin—thyroid cancer	0.00117	0.00117	CcSEcCtD
Tadalafil—Syncope—Epirubicin—thyroid cancer	0.00117	0.00117	CcSEcCtD
Tadalafil—Back pain—Doxorubicin—thyroid cancer	0.00117	0.00117	CcSEcCtD
Tadalafil—Muscle spasms—Doxorubicin—thyroid cancer	0.00116	0.00116	CcSEcCtD
Tadalafil—Palpitations—Epirubicin—thyroid cancer	0.00115	0.00115	CcSEcCtD
Tadalafil—Loss of consciousness—Epirubicin—thyroid cancer	0.00115	0.00115	CcSEcCtD
Tadalafil—Cough—Epirubicin—thyroid cancer	0.00114	0.00114	CcSEcCtD
Tadalafil—Vision blurred—Doxorubicin—thyroid cancer	0.00114	0.00114	CcSEcCtD
Tadalafil—Convulsion—Epirubicin—thyroid cancer	0.00113	0.00113	CcSEcCtD
Tadalafil—Hypertension—Epirubicin—thyroid cancer	0.00113	0.00113	CcSEcCtD
Tadalafil—Arthralgia—Epirubicin—thyroid cancer	0.00111	0.00111	CcSEcCtD
Tadalafil—Myalgia—Epirubicin—thyroid cancer	0.00111	0.00111	CcSEcCtD
Tadalafil—Chest pain—Epirubicin—thyroid cancer	0.00111	0.00111	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.0011	0.0011	CcSEcCtD
Tadalafil—Discomfort—Epirubicin—thyroid cancer	0.0011	0.0011	CcSEcCtD
Tadalafil—Dry mouth—Epirubicin—thyroid cancer	0.00108	0.00108	CcSEcCtD
Tadalafil—Vertigo—Doxorubicin—thyroid cancer	0.00108	0.00108	CcSEcCtD
Tadalafil—Syncope—Doxorubicin—thyroid cancer	0.00108	0.00108	CcSEcCtD
Tadalafil—Palpitations—Doxorubicin—thyroid cancer	0.00107	0.00107	CcSEcCtD
Tadalafil—Oedema—Epirubicin—thyroid cancer	0.00106	0.00106	CcSEcCtD
Tadalafil—Loss of consciousness—Doxorubicin—thyroid cancer	0.00106	0.00106	CcSEcCtD
Tadalafil—Infection—Epirubicin—thyroid cancer	0.00106	0.00106	CcSEcCtD
Tadalafil—Cough—Doxorubicin—thyroid cancer	0.00105	0.00105	CcSEcCtD
Tadalafil—Shock—Epirubicin—thyroid cancer	0.00105	0.00105	CcSEcCtD
Tadalafil—Convulsion—Doxorubicin—thyroid cancer	0.00104	0.00104	CcSEcCtD
Tadalafil—Nervous system disorder—Epirubicin—thyroid cancer	0.00104	0.00104	CcSEcCtD
Tadalafil—Hypertension—Doxorubicin—thyroid cancer	0.00104	0.00104	CcSEcCtD
Tadalafil—Tachycardia—Epirubicin—thyroid cancer	0.00104	0.00104	CcSEcCtD
Tadalafil—Skin disorder—Epirubicin—thyroid cancer	0.00103	0.00103	CcSEcCtD
Tadalafil—Hyperhidrosis—Epirubicin—thyroid cancer	0.00103	0.00103	CcSEcCtD
Tadalafil—Chest pain—Doxorubicin—thyroid cancer	0.00103	0.00103	CcSEcCtD
Tadalafil—Myalgia—Doxorubicin—thyroid cancer	0.00103	0.00103	CcSEcCtD
Tadalafil—Arthralgia—Doxorubicin—thyroid cancer	0.00103	0.00103	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.00102	0.00102	CcSEcCtD
Tadalafil—Discomfort—Doxorubicin—thyroid cancer	0.00101	0.00101	CcSEcCtD
Tadalafil—Dry mouth—Doxorubicin—thyroid cancer	0.001	0.001	CcSEcCtD
Tadalafil—Hypotension—Epirubicin—thyroid cancer	0.000994	0.000994	CcSEcCtD
Tadalafil—Oedema—Doxorubicin—thyroid cancer	0.000984	0.000984	CcSEcCtD
Tadalafil—Infection—Doxorubicin—thyroid cancer	0.000978	0.000978	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000969	0.000969	CcSEcCtD
Tadalafil—Shock—Doxorubicin—thyroid cancer	0.000968	0.000968	CcSEcCtD
Tadalafil—Nervous system disorder—Doxorubicin—thyroid cancer	0.000965	0.000965	CcSEcCtD
Tadalafil—Insomnia—Epirubicin—thyroid cancer	0.000962	0.000962	CcSEcCtD
Tadalafil—Tachycardia—Doxorubicin—thyroid cancer	0.00096	0.00096	CcSEcCtD
Tadalafil—Skin disorder—Doxorubicin—thyroid cancer	0.000956	0.000956	CcSEcCtD
Tadalafil—Paraesthesia—Epirubicin—thyroid cancer	0.000955	0.000955	CcSEcCtD
Tadalafil—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000951	0.000951	CcSEcCtD
Tadalafil—Dyspnoea—Epirubicin—thyroid cancer	0.000948	0.000948	CcSEcCtD
Tadalafil—Somnolence—Epirubicin—thyroid cancer	0.000945	0.000945	CcSEcCtD
Tadalafil—Dyspepsia—Epirubicin—thyroid cancer	0.000936	0.000936	CcSEcCtD
Tadalafil—Hypotension—Doxorubicin—thyroid cancer	0.00092	0.00092	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000918	0.000918	CcSEcCtD
Tadalafil—Fatigue—Epirubicin—thyroid cancer	0.000917	0.000917	CcSEcCtD
Tadalafil—Constipation—Epirubicin—thyroid cancer	0.000909	0.000909	CcSEcCtD
Tadalafil—Pain—Epirubicin—thyroid cancer	0.000909	0.000909	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000897	0.000897	CcSEcCtD
Tadalafil—Insomnia—Doxorubicin—thyroid cancer	0.00089	0.00089	CcSEcCtD
Tadalafil—Paraesthesia—Doxorubicin—thyroid cancer	0.000884	0.000884	CcSEcCtD
Tadalafil—Dyspnoea—Doxorubicin—thyroid cancer	0.000877	0.000877	CcSEcCtD
Tadalafil—Somnolence—Doxorubicin—thyroid cancer	0.000875	0.000875	CcSEcCtD
Tadalafil—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00087	0.00087	CcSEcCtD
Tadalafil—Dyspepsia—Doxorubicin—thyroid cancer	0.000866	0.000866	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.00085	0.00085	CcSEcCtD
Tadalafil—Fatigue—Doxorubicin—thyroid cancer	0.000848	0.000848	CcSEcCtD
Tadalafil—Urticaria—Epirubicin—thyroid cancer	0.000845	0.000845	CcSEcCtD
Tadalafil—Pain—Doxorubicin—thyroid cancer	0.000841	0.000841	CcSEcCtD
Tadalafil—Constipation—Doxorubicin—thyroid cancer	0.000841	0.000841	CcSEcCtD
Tadalafil—Abdominal pain—Epirubicin—thyroid cancer	0.000841	0.000841	CcSEcCtD
Tadalafil—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000805	0.000805	CcSEcCtD
Tadalafil—Hypersensitivity—Epirubicin—thyroid cancer	0.000784	0.000784	CcSEcCtD
Tadalafil—Urticaria—Doxorubicin—thyroid cancer	0.000782	0.000782	CcSEcCtD
Tadalafil—Abdominal pain—Doxorubicin—thyroid cancer	0.000778	0.000778	CcSEcCtD
Tadalafil—Asthenia—Epirubicin—thyroid cancer	0.000763	0.000763	CcSEcCtD
Tadalafil—Pruritus—Epirubicin—thyroid cancer	0.000752	0.000752	CcSEcCtD
Tadalafil—Diarrhoea—Epirubicin—thyroid cancer	0.000728	0.000728	CcSEcCtD
Tadalafil—Hypersensitivity—Doxorubicin—thyroid cancer	0.000725	0.000725	CcSEcCtD
Tadalafil—Asthenia—Doxorubicin—thyroid cancer	0.000706	0.000706	CcSEcCtD
Tadalafil—Dizziness—Epirubicin—thyroid cancer	0.000703	0.000703	CcSEcCtD
Tadalafil—Pruritus—Doxorubicin—thyroid cancer	0.000696	0.000696	CcSEcCtD
Tadalafil—Vomiting—Epirubicin—thyroid cancer	0.000676	0.000676	CcSEcCtD
Tadalafil—Diarrhoea—Doxorubicin—thyroid cancer	0.000673	0.000673	CcSEcCtD
Tadalafil—Rash—Epirubicin—thyroid cancer	0.000671	0.000671	CcSEcCtD
Tadalafil—Dermatitis—Epirubicin—thyroid cancer	0.00067	0.00067	CcSEcCtD
Tadalafil—Headache—Epirubicin—thyroid cancer	0.000666	0.000666	CcSEcCtD
Tadalafil—Dizziness—Doxorubicin—thyroid cancer	0.000651	0.000651	CcSEcCtD
Tadalafil—Nausea—Epirubicin—thyroid cancer	0.000632	0.000632	CcSEcCtD
Tadalafil—Vomiting—Doxorubicin—thyroid cancer	0.000626	0.000626	CcSEcCtD
Tadalafil—Rash—Doxorubicin—thyroid cancer	0.00062	0.00062	CcSEcCtD
Tadalafil—Dermatitis—Doxorubicin—thyroid cancer	0.00062	0.00062	CcSEcCtD
Tadalafil—Headache—Doxorubicin—thyroid cancer	0.000616	0.000616	CcSEcCtD
Tadalafil—Nausea—Doxorubicin—thyroid cancer	0.000585	0.000585	CcSEcCtD
